SEC Form 4 · accession 0001611650-16-000004
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Noreen Griffin
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Mar 28, 2016
Accepted (ET)
Mar 30, 2016 · 7:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WARRANTF1,F2 | $0.20 | Mar 28, 2016 | J | 1 | A | Mar 28, 2016 | Mar 28, 2021 | common stock | 1,000,000 | 1 | D |
Explanation of responses
- F1WARRANT TO PURCHASE UP TO 1 MILLION SHARES OF THE COMPANY'S COMMON STOCK
- F2Warrant to purchase up to 1 million shares of the Company's common stock issued in consideration for the extension of Ms. Griffin's employment contract.